loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 204516 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PAROXETINE MESYLATE (1)

filter

01 SEBELA IRELAND LTD (1)

filter

01 CAPSULE;ORAL (1)

filter

01 EQ 7.5MG BASE (1)

filter

01 USA (1)

URL Supplier Web Content
CAPSULE;ORAL
EQ 7.5MG BASE
BRISDELLE
USA
204516
2013-06-28
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 204516

Looking for CTD TGA MCC DOSSIER APPLICATION 204516 1

19

Sebela Pharmaceuticals, based in U.S.A, is a pharmaceutical company.

One of their notable products is PAROXETINE MESYLATE, with a corresponding application number 204516 and regulatory information .

proudly manufactured in the

approval since 2013-06-28

Sebela Pharmaceuticals's BRISDELLE CAPSULE;ORAL, medication with EQ 7.5MG BASE of PAROXETINE MESYLATE.

Post Enquiry
POST ENQUIRY